This was reduced by the Company's recapitalization to $420.0 million on June 30 , 2003 and has been further reduced to approximately $359 million at December 31 , 2003.
the company indicated that sales by individuals of alaris medical systems' common stock under rule 10b5-1 trading programs announced by the company on november 4 , 2003 have begun.